EDGAR Filing Documents for 0001193125-20-182311

Form SC TO-I - Tender offer statement by Issuer:

SEC Accession No. 0001193125-20-182311

Filing Date

2020-06-29

Accepted

2020-06-29 16:02:43

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	SC TO-I	d935433dsctoi.htm	SC TO-I	54039
2	EX-99.(A)(1)(A)	d935433dex99a1a.htm	EX-99.(A)(1)(A)	216461
3	EX-99.(A)(1)(B)	d935433dex99a1b.htm	EX-99.(A)(1)(B)	8003
4	EX-99.(A)(1)(C)	d935433dex99a1c.htm	EX-99.(A)(1)(C)	40618
5	EX-99.(A)(1)(D)	d935433dex99a1d.htm	EX-99.(A)(1)(D)	13783
6	EX-99.(A)(1)(E)	d935433dex99a1e.htm	EX-99.(A)(1)(E)	3997
7	EX-99.(A)(1(F)	d935433dex99a1f.htm	EX-99.(A)(1(F)	3090
8	EX-99.(A)(1)(G)	d935433dex99a1g.htm	EX-99.(A)(1)(G)	3111
9	EX-99.(A)(1)(H)	d935433dex99a1h.htm	EX-99.(A)(1)(H)	2728
10	EX-99.(A)(1)(I)	d935433dex99a1i.htm	EX-99.(A)(1)(I)	2304
11	EX-99.(A)(1)(J)	d935433dex99a1j.htm	EX-99.(A)(1)(J)	2350
12	EX-99.(A)(1)(K)	d935433dex99a1k.htm	EX-99.(A)(1)(K)	8894
13	GRAPHIC	g935433exa1ks1g1.jpg	GRAPHIC	165094
14	GRAPHIC	g935433exa1ks2g1.jpg	GRAPHIC	97451
15	GRAPHIC	g935433exa1ks3g1.jpg	GRAPHIC	162508
16	GRAPHIC	g935433exa1ks4g1.jpg	GRAPHIC	385791
17	GRAPHIC	g935433exa1ks5g1.jpg	GRAPHIC	188154
18	GRAPHIC	g935433exa1ks6g1.jpg	GRAPHIC	341586
19	GRAPHIC	g935433exa1ks7g1.jpg	GRAPHIC	281434
20	GRAPHIC	g935433exa1ks8g1.jpg	GRAPHIC	403039
21	GRAPHIC	g935433exa1ks9g1.jpg	GRAPHIC	641866
	Complete submission text file	0001193125-20-182311.txt		4035346

Mailing Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121

Business Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121 206-838-0500

Aptevo Therapeutics Inc. (Filed by) CIK: 0001671584 (see all company filings)

IRS No.: 811567056 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC TO-I
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121

Business Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121 206-838-0500

Aptevo Therapeutics Inc. (Subject) CIK: 0001671584 (see all company filings)